A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

Mise à jour : Il y a 4 ans
Référence : NCT00455728

Femme et Homme

Extrait

This study is a multicenter, open label, observational, post marketing surveillance study of NutropinAq® in Austria, France, Germany, Italy, Spain, Romania and United Kingdom to collect long-term safety and effectiveness information on NutropinAq® during treatment of paediatric growth disorders.


Critère d'inclusion

  • Growth Hormone Disorders

Liens